Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: A Study of PF-06873600 in People With Cancer [Phase 1, Phase 2]
Pfizer's PF-06873600 in Phase 1/2 for several cancers was terminated, with results posted in July 2024.
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer
A clinical trial evaluated hypofractionated image-guided radiation therapy for patients with stage IV breast cancer. The study status is com…
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate [Phase 2]
Phase 2 clinical trial update describing a personalized neoadjuvant strategy for ER-positive, HER2-negative breast cancer to raise breast-co…
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors [Phase 2]
A Phase 2 trial evaluating Cediranib in combination with Olaparib in advanced solid tumors has posted results as of 2024-07-30. Indications …
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer [Phase 3]
Phase 3 study evaluating tucatinib plus ado-trastuzumab emtansine (T-DM1) versus placebo plus T-DM1 in advanced or metastatic HER2-positive …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2024-07-30EMA Authorised: Fareston (toremifene) — Orion Corporation
The European Medicines Agency authorised Fareston (toremifene) by Orion Corporation for breast cancer, with the decision dated 26 July 2024.
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer [Phase 1]
Phase 1 study evaluating the addition of copanlisib to fulvestrant and abemaciclib for metastatic breast cancer, with results posted in 2024…
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: Simple Simulation Based Breast Cancer Awareness Training [NA]
A registry entry for a simple simulation-based breast cancer awareness training program that is currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer [Phase 2]
A Phase 2 trial evaluating palbociclib in combination with tamoxifen as first-line therapy for metastatic hormone receptor-positive, HER2-ne…
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: Comparing Efficacy and Safety Between Pertuzumab® and Perjeta® in Neoadjuvant Treatment of HER2+ Breast Cancer [Phase 3]
A Phase 3 trial comparing Pertuzumab (brand name Perjeta) in the neoadjuvant treatment of HER2-positive breast cancer has completed, with re…
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: Study of Irinotecan Liposome Injection in Patients With Advanced Breast Cance [Phase 1]
Phase 1 study of irinotecan liposome injection in patients with advanced breast cancer has completed.
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
The LEARN trial by the University of Sydney is evaluating a new AI-based radiotherapy environment and is currently recruiting across several…
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: Artificial Intelligence Assisted Breast Ultrasound in Breast Cancer Screening [NA]
A completed clinical trial assessing AI-assisted breast ultrasound as a screening tool for breast cancer. The study was sponsored by Fudan U…
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: Laser Speckle Imaging During Breast Reconstruction [NA]
A clinical trial is investigating the use of laser speckle imaging during breast reconstruction for breast cancer. The study is currently re…
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: Cancer Patient Perspectives During COVID-19
This clinical trial update reports a completed study exploring cancer patients' perspectives during the COVID-19 pandemic, focusing on breas…
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer [Phase 2]
A Phase II clinical trial evaluating oral Lucitanib in FGFR1-amplified or non-amplified estrogen receptor-positive metastatic breast cancer …
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer [Phase 2]
Phase 2 trial results evaluate the combination of T-DM1 (ado-trastuzumab emtansine) and palbociclib in metastatic HER2-positive breast cance…
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancer [EARLY_Phase 1]
An early-phase 1 trial evaluating a typhoid vaccine to test immune stress responses in patients with stage I-IIIA breast cancer. Results hav…
-
CLINICAL_TRIALS research · 2024-07-24Clinical Trial Update: Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients
This clinical trial entry describes evaluating circulating tumor DNA dynamics to guide neoadjuvant therapy in patients with HER2-positive br…
-
CLINICAL_TRIALS research · 2024-07-24Clinical Trial Update: Collaborative cOMMUNIty Care for Metastatic breAsT cancEr Patients in inDonesia (Communicated) [NA]
This item reports on a clinical study from Gadjah Mada University about collaborative community care for metastatic breast cancer patients i…
-
CLINICAL_TRIALS research · 2024-07-24Clinical Trial Update: Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors [Phase 1]
This is a Phase 1 clinical trial update for UCMYM802 Injection in mesothelin-positive advanced malignant solid tumors, listing several cance…
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: Effect of Kefir on Symptom Management and Quality of Life in Oncology [NA]
A completed clinical trial investigates whether Kefir improves symptom management and quality of life for patients with breast cancer and co…
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: Southeast Netherlands Advanced Metastatic Breast Cancer Registry
The Southeast Netherlands Advanced Metastatic Breast Cancer Registry (NCT03577197) is currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating BYL719 (alpelisib) with letrozole in post-menopausal women with hormone receptor-positive metastatic breas…
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: Efficacy of Serratus Posterior Intercostal Plane Block for Analgesia and Inflammatory Marker in Breast Surgery [NA]
A clinical trial update on the efficacy of serratus posterior intercostal plane block for analgesia and inflammatory markers in breast surge…